Not exact matches
«We wanted to identify some potential
therapeutic targets that are common not just to one but to multiple forms of retinitis
pigmentosa at late - stage disease, when it is more likely to be clinically diagnosed in a patient population.»
In particular, widespread ocular diseases such as age - related macular degeneration (AMD) and retinitis
pigmentosa (RP), as well as a genetic condition called Stargardt's macular dystrophy (STGD) that afflicts young people, are all potential disease targets for
therapeutic approaches.
The additional capacity of hNPCctx to migrate extensively within the subretinal space and inner retina allows them to deliver molecules of
therapeutic interest not only for outer retinal disease (e.g., retinitis
pigmentosa and age - related macular degeneration), but inner retinal disorders as well (e.g., glaucoma).